Literature DB >> 3001335

E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene.

J T Schiller, W C Vass, K H Vousden, D R Lowy.   

Abstract

We have previously shown that the early region of the bovine papillomavirus type 1 genome contains two nonoverlapping segments that can independently induce the morphological transformation of cultured cells. The transforming gene from the 5' end of the early region is encoded by the E6 open reading frame. The second transforming segment was previously localized to a 2.3-kilobase fragment (2.3T) from the 3' end of the early region. To determine which of the four open reading frames (E2, E3, E4, and E5) located within 2.3T encodes a transforming gene, we have now introduced a series of insertion and deletion mutations into a clone (pHLB1) in which 2.3T is activated by the Harvey viral long terminal repeat, and we tested the mutants for their ability to induce focal transformation. Our results indicate that the E5 open reading frame, which could encode a low-molecular-weight hydrophobic peptide, is required for pHLB1-induced transformation of NIH 3T3 cells, but that the E2, E3, and E4 open reading frames are not.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3001335      PMCID: PMC252691     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Helper-independent transformation by unintegrated Harvey sarcoma virus DNA.

Authors:  D R Lowy; E Rands; E M Scolnick
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

2.  Genetic analysis of bovine papillomavirus type 1 trans-acting replication factors.

Authors:  M Lusky; M R Botchan
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA.

Authors:  D R Lowy; I Dvoretzky; R Shober; M F Law; L Engel; P M Howley
Journal:  Nature       Date:  1980-09-04       Impact factor: 49.962

5.  Virus-specific transcription in bovine papillomavirus-transformed mouse cells.

Authors:  C A Heilman; L Engel; D R Lowy; P M Howley
Journal:  Virology       Date:  1982-05       Impact factor: 3.616

6.  Messenger RNAs from the transforming region of bovine papilloma virus type I.

Authors:  A Stenlund; J Zabielski; H Ahola; J Moreno-Lopez; U Pettersson
Journal:  J Mol Biol       Date:  1985-04-20       Impact factor: 5.469

7.  Genomic structure of the cottontail rabbit (Shope) papillomavirus.

Authors:  I Giri; O Danos; M Yaniv
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

8.  Bovine papillomavirus contains multiple transforming genes.

Authors:  Y C Yang; H Okayama; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences.

Authors:  M F Law; D R Lowy; I Dvoretzky; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  83 in total

1.  Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation.

Authors:  Frauke Fehrmann; David J Klumpp; Laimonis A Laimins
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase.

Authors:  D J Goldstein; R Kulke; D Dimaio; R Schlegel
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells.

Authors:  L Petti; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

4.  HUMAN PAPILLOMAVIRUS ASSOCIATION WITH HEAD AND NECK CANCERS: UNDERSTANDING VIRUS BIOLOGY AND USING IT IN THE DEVELOPMENT OF CANCER DIAGNOSTICS.

Authors:  Katerina Strati; Paul F Lambert
Journal:  Expert Opin Med Diagn       Date:  2008-01-01

5.  HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions.

Authors:  Douglas R Lowy
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

6.  Progression of the phenotype of transformed cells after growth stimulation of cells by a human papillomavirus type 16 gene function.

Authors:  T Noda; H Yajima; Y Ito
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

7.  Reindeer papillomavirus transforming properties correlate with a highly conserved E5 region.

Authors:  J Moreno-Lopez; H Ahola; A Eriksson; P Bergman; U Pettersson
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

8.  Mutational analysis of bovine papillomavirus type 1 E5 peptide domains involved in induction of cellular DNA synthesis.

Authors:  J A Rawls; P M Loewenstein; M Green
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Genetic evidence that acute morphologic transformation, induction of cellular DNA synthesis, and focus formation are mediated by a single activity of the bovine papillomavirus E5 protein.

Authors:  J Settleman; A Fazeli; J Malicki; B H Horwitz; D DiMaio
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

10.  The genomes of the animal papillomaviruses European elk papillomavirus, deer papillomavirus, and reindeer papillomavirus contain a novel transforming gene (E9) near the early polyadenylation site.

Authors:  A Eriksson; A C Stewart; J Moreno-Lopéz; U Pettersson
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.